Use of sphingolipid analogs: benefits and risks.
Ghidoni
R
R
INSERM U410, Neuroendocrinologie et Biologie Cellulaire Digestives, Faculté de Médecine Xavier Bichat, Paris, France. Riccardo.Ghidoni@unimi.it
Sala
G
G
Giuliani
A
A
D002518:Ceramides / Q000737:chemistry; D005232:Fatty Acids, Volatile / Q000737:chemistry; D005456:Fluorescent Dyes; D012107:Research Design; D013107:Sphingolipids / Q000737:chemistry*; D013110:Sphingosine / Q000031:analogs & derivatives; D013113:Spin Labels; D013237:Stereoisomerism
D002518:Ceramides; D005232:Fatty Acids, Volatile; D005456:Fluorescent Dyes; D013107:Sphingolipids; D013113:Spin Labels; D013110:Sphingosine